IMARC Group, a leading market research company, has released a report titled “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global dry eye syndrome market trends. The global market size reached US$ 4.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.67% during 2023-2028.

Dry eye syndrome is a common eye condition characterized by a lack of sufficient lubrication and moisture on the surface of the eye. This can result in symptoms like irritation, redness, a gritty feeling, and sometimes blurred vision. Dry eye syndrome may be caused by various factors, such as age, environmental conditions, or certain medications. It can also be a symptom of other health issues like autoimmune diseases. Its treatment often involves over-the-counter eye drops, prescription medication, or, in severe cases, surgical interventions. Proper diagnosis and management by an eye care professional are essential for effective treatment and relief from symptoms. In recent years, dry eye syndrome treatment is gaining immense traction across the globe due to the rising prevalence of the disease.

Request Your Sample Report Now: https://www.imarcgroup.com/dry-eye-syndrome-market/requestsample

Dry Eye Syndrome Market Trends and Drivers:

The global dry eye syndrome market is primarily driven by an expanding aging population that is more susceptible to dry eye symptoms. Moreover, numerous environmental factors like pollution and climate change have escalated the prevalence rates, thereby fueling market growth. Apart from this, the rising awareness about eye health and the availability of advanced diagnostic tools are encouraging patients to seek treatment, thereby propelling market growth. Besides this, numerous technological advancements in dry eye management, such as innovative ocular surface treatments, are another major growth-inducing factor. Furthermore, the rising cases of computer vision syndrome owing to the increasing screen time and digital device usage are contributing to market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Disease Type Insights:

  • Evaporative Dry Eye Syndrome 
  • Aqueous Dry Eye Syndrome 

Drug Type Insights:

  • Anti-inflammatory Drugs
  • Lubricant Eye Drops
  • Autologous Serum Eye Drops

Product Insights:

  • Liquid Drops
  • Gel
  • Liquid Wipes
  • Eye Ointment
  • Others

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Akorn Operating Company LLC
  • Alimera Science
  • Allergan plc.
  • Auven Therapeutics
  • Bausch + Lomb Incorporated
  • GlaxoSmithKline plc
  • Nicox S.A.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal